SCHEMBL6851560

SCHEMBL6851560

CCc1cn([C@@H]2O[C@H](CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DNPH1 O43598 1/20 0.50
P2RY2 P41231 2/20 0.44
P2RY6 Q15077 9/20 0.42
P2RY14 Q15391 6/20 0.42
NT5E P21589 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668666 0.90 P2RY2 (0.44) DNPH1P2RY2P2RY6P2RY14NT5E
SCHEMBL8171833 0.89 DNPH1 (0.41) DNPH1
SCHEMBL8171834 0.89 DNPH1 (0.41) DNPH1
SCHEMBL7811414 0.88 P2RY6 (0.54) DNPH1P2RY2P2RY6P2RY14NT5E
SCHEMBL7901418 0.87 DNPH1 (0.38) DNPH1
SCHEMBL7901416 0.87 DNPH1 (0.38) DNPH1
SCHEMBL10645210 0.86 DNPH1 (0.41) DNPH1NT5E
SCHEMBL10647159 0.86 DNPH1 (0.41) DNPH1NT5E
SCHEMBL10645235 0.85 DNPH1 (0.41) DNPH1P2RY2P2RY6P2RY14NT5E
SCHEMBL10643486 0.85 DNPH1 (0.41) DNPH1P2RY2P2RY6P2RY14NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465905-A2 ANTISENSE MODULATION OF MYD88 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2004-10-13 EP disclosed
EP-1328536-A1 ANTISENSE MODULATION OF GLIOMA-ASSOCIATED ONCOGENE-1 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2003-07-23 EP disclosed
WO-2003049691-A2 ANTISENSE MODULATION OF PCTAIRE PROTEIN KINASE 1 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2003-06-19 WO disclosed
WO-2003046132-A2 ANTISENSE MODULATION OF MYD88 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2003-06-05 WO disclosed
WO-2002020549-A1 ANTISENSE MODULATION OF GLIOMA-ASSOCIATED ONCOGENE-1 EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2002-03-14 WO disclosed